# LTGO (Latigo Biotherapeutics, Inc.) - SEC EDGAR Financial Statements

> Latigo Biotherapeutics, Inc. reported $408.5M in total assets through September 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/LTGO
- Markdown: https://convexityos.com/fundamentals/LTGO.md
- SEC CIK: 0002056611
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:32 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002056611&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Sep 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $401.2M | Total debt: $1.19M |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $17.50M | $21.23M | -- | $22.10M | $22.92M | -- |
| Total Operating Expenses | $22.93M | $25.81M | -- | $24.72M | $25.75M | -- |
| **Operating Income** | -$22.93M | -$25.81M | -- | -$24.72M | -$25.75M | -- |
| **EBITDA** | -$22.83M | -$25.71M | -- | -$24.62M | -$25.64M | -- |
| Interest Expense | $699K | $251K | -- | $0 | $0 | -- |
| Income Tax Expense | $0 | $0 | -- | $0 | $0 | -- |
| **Net Income** | -$20.95M | -$25.80M | -$22.96M | -$24.80M | -$25.84M | -$20.95M |
| Basic EPS | -$0.55 | -$27.59 | -- | -$29.50 | -$36.52 | -- |
| **Diluted EPS** | -$0.55 | -$27.59 | -- | -$29.50 | -$36.52 | -- |
| Basic Shares Outstanding | 37.8M | 935.0K | -- | 840.4K | 707.5K | -- |
| Diluted Shares Outstanding | 37.8M | 935.0K | -- | 840.4K | 707.5K | -- |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Dec 2025 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $401.2M | $55.00M | $69.44M |
| **Cash & Short-Term Investments** | $401.2M | $55.00M | $69.44M |
| **Total Current Assets** | $406.4M | $59.20M | $73.83M |
| Property, Plant & Equipment, Net | $440K | $457K | $446K |
| Other Non-Current Assets | $433K | $3.80M | $616K |
| **Total Non-Current Assets** | $2.01M | $5.56M | $1.69M |
| **Total Assets** | $408.5M | $64.76M | $75.52M |
| Accounts Payable | $5.08M | $3.57M | $5.01M |
| **Total Current Liabilities** | $13.96M | $51.58M | $18.45M |
| Other Non-Current Liabilities | $35K | $35K | $35K |
| **Total Non-Current Liabilities** | $518K | $683K | $162K |
| **Total Liabilities** | $14.48M | $52.26M | $18.61M |
| **Total Debt (incl. Leases)** | $1.19M | $1.35M | $690K |
| Common Stock | $7.0K | $0 | $0 |
| Retained Earnings | -$312.8M | -$291.9M | -$243.1M |
| **Total Stockholders' Equity** | $394.0M | -$276.1M | -$231.7M |
| Total Equity | $394.0M | -$276.1M | -$231.7M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$20.95M | -$25.80M | -$22.96M | -$24.80M | -$25.84M | -$20.95M |
| Depreciation & Amortization | $100K | $100K | -- | $100K | $100K | -- |
| Stock-Based Compensation | $2.54M | $2.14M | -- | $1.82M | $1.68M | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 29.11x | 1.15x | -- | -- | -- | -- |
| Quick Ratio | 28.73x | 1.07x | -- | -- | -- | -- |
| Debt to Equity | 0.00x | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
